Comorbid pathology in patients with late-stage ankylosing spondylitis

Objective: to investigate the frequency and characteristics of comorbid diseases in patients with late-stage ankylosing spondylitis (AS).Material and methods. The study includes 40 men aged 33–67 with late-stage AS (main group) and 40 patients with a cardiovascular conditions (control group). We ana...

Full description

Saved in:
Bibliographic Details
Main Authors: E. S. Yushina, E. V. Zonova, E. B. Luksha, D. N. Orlov, V. V. Rerikh, V. N. Koksharova
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2025-04-01
Series:Современная ревматология
Subjects:
Online Access:https://mrj.ima-press.net/mrj/article/view/1742
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849691178690150400
author E. S. Yushina
E. V. Zonova
E. B. Luksha
D. N. Orlov
V. V. Rerikh
V. N. Koksharova
author_facet E. S. Yushina
E. V. Zonova
E. B. Luksha
D. N. Orlov
V. V. Rerikh
V. N. Koksharova
author_sort E. S. Yushina
collection DOAJ
description Objective: to investigate the frequency and characteristics of comorbid diseases in patients with late-stage ankylosing spondylitis (AS).Material and methods. The study includes 40 men aged 33–67 with late-stage AS (main group) and 40 patients with a cardiovascular conditions (control group). We analyzed clinical characteristics of AS in patients of the main group. In addition, echocardiography (EcoCG) and ultrasound of brachiocephalic arteries (BCA) were done in patients of both groups to assess patients' cardiovascular condition.Results and discussion. The mean age of the patients was 49.90±9.44 years, and the mean duration of the disease was 24.07±9.72 years. 85% of patients suffered from arterial hypertension (AH), mainly grade 1 and 2 (37.5% each). Body mass index >25 kg/m2 was found in 55.0% (n=22) of patients, predominantly grade 1 and 2 (30.0%, n=12). Hypercholesterolemia was found in 62.5% of patients and an increase in lowdensity lipoprotein cholesterol in 57.5%. The incidence of diabetes mellitus (DM) was 10%. DM type 2 and LADA were found in a ratio of 1:1 (5.0% each). The differences in results of EcoCG and BCA ultrasound in the main and control group were not statistically significant.Conclusion. AH and metabolic disorders occupy the leading place among cardiovascular diseases (CVD) in patients with stable spinal deformity, which can be considered as an additional risk factor for CVD. The data obtained indicate the need to assess cardiovascular risks at an early stage of AS to prevent CVD.
format Article
id doaj-art-168a79bcbf1346b5990bdf03a2ccba0a
institution DOAJ
issn 1996-7012
2310-158X
language Russian
publishDate 2025-04-01
publisher IMA-PRESS LLC
record_format Article
series Современная ревматология
spelling doaj-art-168a79bcbf1346b5990bdf03a2ccba0a2025-08-20T03:21:07ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2025-04-01192707710.14412/1996-7012-2025-2-70-772777Comorbid pathology in patients with late-stage ankylosing spondylitisE. S. Yushina0E. V. Zonova1E. B. Luksha2D. N. Orlov3V. V. Rerikh4V. N. Koksharova5Novosibirsk State Medical University, Ministry of Health of Russia; City Clinical Polyclinic №1Novosibirsk State Medical University, Ministry of Health of Russia; City Clinical Polyclinic №1Novosibirsk State Medical University, Ministry of Health of Russia; City Clinical Hospital No.1City Clinical Polyclinic №1Novosibirsk State Medical University, Ministry of Health of Russia; Novosibirsk Research Institute of Traumatology and Orthopedics named after Y. L. TsivyanCity Clinical Polyclinic №1Objective: to investigate the frequency and characteristics of comorbid diseases in patients with late-stage ankylosing spondylitis (AS).Material and methods. The study includes 40 men aged 33–67 with late-stage AS (main group) and 40 patients with a cardiovascular conditions (control group). We analyzed clinical characteristics of AS in patients of the main group. In addition, echocardiography (EcoCG) and ultrasound of brachiocephalic arteries (BCA) were done in patients of both groups to assess patients' cardiovascular condition.Results and discussion. The mean age of the patients was 49.90±9.44 years, and the mean duration of the disease was 24.07±9.72 years. 85% of patients suffered from arterial hypertension (AH), mainly grade 1 and 2 (37.5% each). Body mass index >25 kg/m2 was found in 55.0% (n=22) of patients, predominantly grade 1 and 2 (30.0%, n=12). Hypercholesterolemia was found in 62.5% of patients and an increase in lowdensity lipoprotein cholesterol in 57.5%. The incidence of diabetes mellitus (DM) was 10%. DM type 2 and LADA were found in a ratio of 1:1 (5.0% each). The differences in results of EcoCG and BCA ultrasound in the main and control group were not statistically significant.Conclusion. AH and metabolic disorders occupy the leading place among cardiovascular diseases (CVD) in patients with stable spinal deformity, which can be considered as an additional risk factor for CVD. The data obtained indicate the need to assess cardiovascular risks at an early stage of AS to prevent CVD.https://mrj.ima-press.net/mrj/article/view/1742ankylosing spondylitislate-stagekyphosisspinal deformitycardiovascular diseasearterial hypertensionmetabolic disorders
spellingShingle E. S. Yushina
E. V. Zonova
E. B. Luksha
D. N. Orlov
V. V. Rerikh
V. N. Koksharova
Comorbid pathology in patients with late-stage ankylosing spondylitis
Современная ревматология
ankylosing spondylitis
late-stage
kyphosis
spinal deformity
cardiovascular disease
arterial hypertension
metabolic disorders
title Comorbid pathology in patients with late-stage ankylosing spondylitis
title_full Comorbid pathology in patients with late-stage ankylosing spondylitis
title_fullStr Comorbid pathology in patients with late-stage ankylosing spondylitis
title_full_unstemmed Comorbid pathology in patients with late-stage ankylosing spondylitis
title_short Comorbid pathology in patients with late-stage ankylosing spondylitis
title_sort comorbid pathology in patients with late stage ankylosing spondylitis
topic ankylosing spondylitis
late-stage
kyphosis
spinal deformity
cardiovascular disease
arterial hypertension
metabolic disorders
url https://mrj.ima-press.net/mrj/article/view/1742
work_keys_str_mv AT esyushina comorbidpathologyinpatientswithlatestageankylosingspondylitis
AT evzonova comorbidpathologyinpatientswithlatestageankylosingspondylitis
AT ebluksha comorbidpathologyinpatientswithlatestageankylosingspondylitis
AT dnorlov comorbidpathologyinpatientswithlatestageankylosingspondylitis
AT vvrerikh comorbidpathologyinpatientswithlatestageankylosingspondylitis
AT vnkoksharova comorbidpathologyinpatientswithlatestageankylosingspondylitis